메뉴 건너뛰기




Volumn 4, Issue 3, 2013, Pages 190-196

Long-term miglitol administration suppresses postprandial glucose-dependent insulinotropic polypeptide secretion

Author keywords

Diabetes mellitus; Glucose dependent insulinotropic polypeptide; Miglitol; Glucosidase inhibitor

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE; INSULIN; MIGLITOL; MITIGLINIDE; NATEGLINIDE; TRIACYLGLYCEROL;

EID: 84884886682     PISSN: 21901678     EISSN: 21901686     Source Type: Journal    
DOI: 10.1007/s13340-013-0116-0     Document Type: Article
Times cited : (4)

References (24)
  • 1
    • 0037097039 scopus 로고    scopus 로고
    • Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
    • STOP-NIDDM Trail Research Group
    • Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M, STOP-NIDDM Trail Research Group. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359: 2072-7.
    • (2002) Lancet , vol.359 , pp. 2072-2077
    • Chiasson, J.L.1    Josse, R.G.2    Gomis, R.3    Hanefeld, M.4    Karasik, A.5    Laakso, M.6
  • 2
    • 60049089801 scopus 로고    scopus 로고
    • Miglitol induces prolonged and enhanced glucagon-like peptide-1 and reduced gastric inhibitory polypeptide responses after ingestion of a mixed meal in Japanese type 2 diabetic patients
    • Narita T, Katsuura Y, Sato T. Miglitol induces prolonged and enhanced glucagon-like peptide-1 and reduced gastric inhibitory polypeptide responses after ingestion of a mixed meal in Japanese type 2 diabetic patients. Diabet Med. 2009;26: 187-8.
    • (2009) Diabet Med , vol.26 , pp. 187-188
    • Narita, T.1    Katsuura, Y.2    Sato, T.3
  • 3
    • 0036708117 scopus 로고    scopus 로고
    • The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics
    • Lee A, Patrick P, Wishart J, Horowitz M, Morley JE. The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics. Diabetes Obes Metab. 2002;4: 329-35.
    • (2002) Diabetes Obes Metab , vol.4 , pp. 329-335
    • Lee, A.1    Patrick, P.2    Wishart, J.3    Horowitz, M.4    Morley, J.E.5
  • 5
    • 34447127048 scopus 로고    scopus 로고
    • Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets
    • Gault VA, McClean PL, Cassidy RS, Irwin N, Flatt PR. Chemical gastric inhibitory polypeptide receptor antagonism protects against obesity, insulin resistance, glucose intolerance and associated disturbances in mice fed high-fat and cafeteria diets. Diabetologia. 2007;50: 1752-62.
    • (2007) Diabetologia , vol.50 , pp. 1752-1762
    • Gault, V.A.1    McClean, P.L.2    Cassidy, R.S.3    Irwin, N.4    Flatt, P.R.5
  • 6
    • 0019865836 scopus 로고
    • Rise in plasma concentration of aldosterone during long-term angiotensin II suppression
    • Staessen J, Lijnen P, Fagard R, Verschueren LJ, Amery A. Rise in plasma concentration of aldosterone during long-term angiotensin II suppression. J Endocrinol. 1981;91(3): 457-65.
    • (1981) J Endocrinol , vol.91 , Issue.3 , pp. 457-465
    • Staessen, J.1    Lijnen, P.2    Fagard, R.3    Verschueren, L.J.4    Amery, A.5
  • 7
    • 0034006999 scopus 로고    scopus 로고
    • Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus
    • Scott LJ, Spencer CM. Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus. Drugs. 2000;59: 521-49.
    • (2000) Drugs , vol.59 , pp. 521-549
    • Scott, L.J.1    Spencer, C.M.2
  • 8
    • 79952173246 scopus 로고    scopus 로고
    • Comparing the efficacy of α-glucosidase inhibitors in suppressing postprandial hyperglycemia using continuous glucose monitoring: a pilot study-the MAJOR study
    • Tsujino D, Nishimura R, Taki K, Morimoto A, Tajima N, Utsunomiya K. Comparing the efficacy of α-glucosidase inhibitors in suppressing postprandial hyperglycemia using continuous glucose monitoring: a pilot study-the MAJOR study. Diabetes Technol Ther. 2011;13(3): 303-8.
    • (2011) Diabetes Technol Ther , vol.13 , Issue.3 , pp. 303-308
    • Tsujino, D.1    Nishimura, R.2    Taki, K.3    Morimoto, A.4    Tajima, N.5    Utsunomiya, K.6
  • 9
    • 83555168228 scopus 로고    scopus 로고
    • Effect of 3-month repeated administration of miglitol on vascular endothelial function in patients with diabetes mellitus and coronary artery disease
    • Emoto T, Sawada T, Yokoyama M. Effect of 3-month repeated administration of miglitol on vascular endothelial function in patients with diabetes mellitus and coronary artery disease. Am J Cardiol. 2012;109(1): 42-6.
    • (2012) Am J Cardiol , vol.109 , Issue.1 , pp. 42-46
    • Emoto, T.1    Sawada, T.2    Yokoyama, M.3
  • 10
    • 0030972122 scopus 로고    scopus 로고
    • The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone
    • Segal P, Feig PU, Schernthaner G. The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone. Diabetes Care. 1997;20: 687-91.
    • (1997) Diabetes Care , vol.20 , pp. 687-691
    • Segal, P.1    Feig, P.U.2    Schernthaner, G.3
  • 11
    • 33745678261 scopus 로고    scopus 로고
    • The test meal A:A pilot model for the international standard of test meal for an assessment of both postprandial hyperglycemia and hyperlipidemia
    • Yoshino G. The test meal A: A pilot model for the international standard of test meal for an assessment of both postprandial hyperglycemia and hyperlipidemia. J Jpn Diabetes Soc. 2006;49: 361-71.
    • (2006) J Jpn Diabetes Soc , vol.49 , pp. 361-371
    • Yoshino, G.1
  • 12
    • 77955790218 scopus 로고    scopus 로고
    • Report of the Committee on the classification and diagnostic criteria of diabetes mellitus
    • The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus
    • The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc. 2010;53: 450-67.
    • (2010) J Jpn Diabetes Soc , vol.53 , pp. 450-467
  • 13
    • 0012184784 scopus 로고
    • Insulin as a cause of extreme hyperglycemia and instability
    • Somogyi M. Insulin as a cause of extreme hyperglycemia and instability. Week Bull St Louis Med Soc. 1938;32: 498-510.
    • (1938) Week Bull St Louis Med Soc , vol.32 , pp. 498-510
    • Somogyi, M.1
  • 14
    • 48849115247 scopus 로고    scopus 로고
    • Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects
    • Arakawa M. Miglitol suppresses the postprandial increase in interleukin 6 and enhances active glucagon-like peptide 1 secretion in viscerally obese subjects. Metabolism. 2008;57: 1299-306.
    • (2008) Metabolism , vol.57 , pp. 1299-1306
    • Arakawa, M.1
  • 15
    • 17144398850 scopus 로고    scopus 로고
    • α-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in type 2 diabetic patients
    • Hücking K, Kostic Z, Pox C. α-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in type 2 diabetic patients. Diabet Med. 2005;22: 470-6.
    • (2005) Diabet Med , vol.22 , pp. 470-476
    • Hücking, K.1    Kostic, Z.2    Pox, C.3
  • 17
    • 77952267060 scopus 로고    scopus 로고
    • Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study
    • Kato T, Inoue T, Node K. Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study. Cardiovasc Diabetol. 2010;9: 12.
    • (2010) Cardiovasc Diabetol , vol.9 , pp. 12
    • Kato, T.1    Inoue, T.2    Node, K.3
  • 18
    • 0031820109 scopus 로고    scopus 로고
    • Asymptomatic hyperglycaemia and early atherosclerotic changes
    • Kawamori R. Asymptomatic hyperglycaemia and early atherosclerotic changes. Diabetes Res Clin Pract. 1998;40: S35-42.
    • (1998) Diabetes Res Clin Pract , vol.40
    • Kawamori, R.1
  • 19
    • 77954501338 scopus 로고    scopus 로고
    • Single administration of α-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease
    • Hiki M, Shimada K. Single administration of α-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease. Circ J. 2010;74: 1471-8.
    • (2010) Circ J , vol.74 , pp. 1471-1478
    • Hiki, M.1    Shimada, K.2
  • 20
    • 0029886788 scopus 로고    scopus 로고
    • Improvement of insulin sensitivity and dyslipidemia with a new alpha-glucosidase inhibitor, voglibose, in nondiabetic hyperinsulinemic subjects
    • Shinozaki K, Suzuki M, Ikebuchi M, Hirose J, Hara Y, Harano Y. Improvement of insulin sensitivity and dyslipidemia with a new alpha-glucosidase inhibitor, voglibose, in nondiabetic hyperinsulinemic subjects. Metabolism. 1996;45: 731-7.
    • (1996) Metabolism , vol.45 , pp. 731-737
    • Shinozaki, K.1    Suzuki, M.2    Ikebuchi, M.3    Hirose, J.4    Hara, Y.5    Harano, Y.6
  • 21
    • 0002633391 scopus 로고
    • Decreased GIP secretion through impairment of absorption
    • Ebert R, Creutzfeldt W. Decreased GIP secretion through impairment of absorption. Front Horm Res. 1980;7: 192-210.
    • (1980) Front Horm Res , vol.7 , pp. 192-210
    • Ebert, R.1    Creutzfeldt, W.2
  • 22
    • 0035954846 scopus 로고    scopus 로고
    • Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus
    • Ginsberg HN, Illingworth DR. Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus. Am J Cardiol. 2001;88: 09-15.
    • (2001) Am J Cardiol , vol.88 , pp. 09-15
    • Ginsberg, H.N.1    Illingworth, D.R.2
  • 23
    • 4444293785 scopus 로고    scopus 로고
    • Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes
    • Ogawa S, Takeuchi K, Ito S. Acarbose lowers serum triglyceride and postprandial chylomicron levels in type 2 diabetes. Diabetes Obes Metab. 2004;6: 384-90.
    • (2004) Diabetes Obes Metab , vol.6 , pp. 384-390
    • Ogawa, S.1    Takeuchi, K.2    Ito, S.3
  • 24
    • 84857034273 scopus 로고    scopus 로고
    • Comparisons of the effects of 12-week administration of miglitol and voglibose on the responses of plasma incretins after a mixed meal in Japanese type 2 diabetic patients
    • Narita T, Yokoyama H, Yamashita R, Sato T, Hosoba M, Morii T, Fujita H, Tsukiyama K, Yamada Y. Comparisons of the effects of 12-week administration of miglitol and voglibose on the responses of plasma incretins after a mixed meal in Japanese type 2 diabetic patients. Diabetes Obes Metab. 2012;14(3): 283-7.
    • (2012) Diabetes Obes Metab , vol.14 , Issue.3 , pp. 283-287
    • Narita, T.1    Yokoyama, H.2    Yamashita, R.3    Sato, T.4    Hosoba, M.5    Morii, T.6    Fujita, H.7    Tsukiyama, K.8    Yamada, Y.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.